| Mammographic features and breast cancer risk: effects with time, age, and menopause status C Byrne, C Schairer, J Wolfe, N Parekh, M Salane, LA Brinton, R Hoover, ... JNCI: Journal of the National Cancer Institute 87 (21), 1622-1629, 1995 | 1107 | 1995 |
| Proportion of breast cancer cases in the United States explained by well-established risk factors MP Madigan, RG Ziegler, J Benichou, C Byrne, RN Hoover JNCI: Journal of the National Cancer Institute 87 (22), 1681-1685, 1995 | 934 | 1995 |
| Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention B Rockhill, D Spiegelman, C Byrne, DJ Hunter, GA Colditz Journal of the National Cancer Institute 93 (5), 358-366, 2001 | 615 | 2001 |
| Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density J Chen, D Pee, R Ayyagari, B Graubard, C Schairer, C Byrne, J Benichou, ... Journal of the National Cancer Institute 98 (17), 1215-1226, 2006 | 435 | 2006 |
| Radial scars in benign breast-biopsy specimens and the risk of breast cancer TW Jacobs, C Byrne, G Colditz, JL Connolly, SJ Schnitt New England Journal of Medicine 340 (6), 430-436, 1999 | 421 | 1999 |
| Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women RM Tamimi, C Byrne, GA Colditz, SE Hankinson Journal of the National Cancer Institute 99 (15), 1178-1187, 2007 | 347 | 2007 |
| Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. LM Marshall, DJ Hunter, JL Connolly, SJ Schnitt, C Byrne, SJ London, ... Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1997 | 346 | 1997 |
| Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density C Byrne, GA Colditz, WC Willett, FE Speizer, M Pollak, SE Hankinson Cancer research 60 (14), 3744-3748, 2000 | 329 | 2000 |
| Metals and breast cancer C Byrne, SD Divekar, GB Storchan, DA Parodi, MB Martin Journal of mammary gland biology and neoplasia 18, 63-73, 2013 | 241 | 2013 |
| Cadmium—a metallohormone? C Byrne, SD Divekar, GB Storchan, DA Parodi, MB Martin Toxicology and applied pharmacology 238 (3), 266-271, 2009 | 241 | 2009 |
| Twenty‐year follow‐up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project CR Smart, C Byrne, RA Smith, L Garfinkel, AH Letton, GD Dodd, ... CA: a cancer journal for clinicians 47 (3), 134-149, 1997 | 212 | 1997 |
| Estrogen replacement therapy and breast cancer survival in a large screening study C Schairer, M Gail, C Byrne, PS Rosenberg, SR Sturgeon, LA Brinton, ... Journal of the National Cancer Institute 91 (3), 264-270, 1999 | 194 | 1999 |
| Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States) C Schairer, C Byrne, PM Keyl, LA Brinton, SR Sturgeon, RN Hoover Cancer Causes & Control 5, 491-500, 1994 | 191 | 1994 |
| Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States) C Schairer, C Byrne, PM Keyl, LA Brinton, SR Sturgeon, RN Hoover Cancer Causes & Control 5, 491-500, 1994 | 191 | 1994 |
| Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research MB Terry, KB Michels, JG Brody, C Byrne, S Chen, DJ Jerry, KMC Malecki, ... Breast cancer research 21, 1-16, 2019 | 184 | 2019 |
| Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density C Diorio, M Pollak, C Byrne, B Mâsse, N Hébert-Croteau, M Yaffe, ... Cancer Epidemiology Biomarkers & Prevention 14 (5), 1065-1073, 2005 | 181 | 2005 |
| Endogenous sex hormone levels and mammographic density among postmenopausal women RM Tamimi, SE Hankinson, GA Colditz, C Byrne Cancer Epidemiology Biomarkers & Prevention 14 (11), 2641-2647, 2005 | 162 | 2005 |
| Effects of mammographic density and benign breast disease on breast cancer risk (United States) C Byrne, C Schairer, LA Brinton, J Wolfe, N Parekh, M Salane, C Carter, ... Cancer Causes & Control 12, 103-110, 2001 | 158 | 2001 |
| Mammographic density change with estrogen and progestin therapy and breast cancer risk C Byrne, G Ursin, CF Martin, JD Peck, EB Cole, D Zeng, E Kim, MD Yaffe, ... JNCI: Journal of the National Cancer Institute 109 (9), djx001, 2017 | 152 | 2017 |
| Vitamin D and calcium intakes from food or supplements and mammographic breast density S Bérubé, C Diorio, B Mâsse, N Hébert-Croteau, C Byrne, G Côté, ... Cancer Epidemiology Biomarkers & Prevention 14 (7), 1653-1659, 2005 | 129 | 2005 |
Graham Colditz, MD, DrPHProfessor, Dept. of Surgery, Washington University in St. LouisPotvrđena adresa e-pošte na wustl.edu